HAE has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Haemonetics Corporation's account receivable for the three months ended in Dec. 2013 was $149.6 Mil. Haemonetics Corporation's revenue for the three months ended in Dec. 2013 was $242.1 Mil. Hence, Haemonetics Corporation's days sales outstanding for the three months ended in Dec. 2013 was 56.22.
Haemonetics Corporation's days sales outstanding declined from Dec. 2012 (61.56) to Dec. 2013 (56.22).
Days sales outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
Account receivable can be measured by Days Sales Outstanding.
Haemonetics Corporation's Days Sales Outstanding for the fiscal year that ended in Mar. 2013 is calculated as
Haemonetics Corporation's Days Sales Outstanding for the quarter that ended in Dec. 2013 is calculated as:
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Haemonetics Corporation Annual Data
Haemonetics Corporation Quarterly Data